- Home
- SANA
as 01-21-2025 4:00pm EST
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 522.4M | IPO Year: | 2021 |
| Target Price: | $13.00 | AVG Volume (30 days): | 14.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.52 - $12.00 | Next Earning Date: | 02-27-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Sana Biotechnology Inc. (SANA)
Latest Sana Biotechnology Inc. News
SANA Breaking Stock News: Dive into SANA Ticker-Specific Updates for Smart Investing
Zacks
12 days ago
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data
GlobeNewswire
13 days ago
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
MT Newswires
14 days ago
Sector Update: Health Care Stocks Higher in Afternoon Trading
MT Newswires
14 days ago
Top Midday Gainers
MT Newswires
14 days ago
Sana Biotechnology Shares Surge After Diabetes Study Results, TD Cowen Upgrade
Insider Monkey
14 days ago
Sana Biotechnology (SANA), eBay (EBAY) Are Among Today’s Big Winners
Barrons.com
14 days ago
This Biotech Stock Soared 300% Overnight. Why It Can Go Higher.
MT Newswires
14 days ago
TD Cowen Upgrades Sana Biotechnology to Buy From Hold
Compare SANA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SANA Sana Biotechnology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.